ADO and neoplasm: To address the issues of the multi-step complexity, target heterogeneity, and limitations of single interventions, combined strategies for ADO-mediated immunosuppression is conducted through synergistic intervention in different metabolic nodes, ultimately enhancing anti-tumor immunity or reversing pathological states (140, 141).